Regeneron Pharmaceuticals, Inc. - Product Pipeline Review - 2016

  • ID: 3743750
  • Company Profile
  • 101 pages
  • Global Markets Direct
  • Regeneron Pharmaceuticals Inc
1 of 4
Regeneron Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

‘Regeneron Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Regeneron Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Regeneron Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Regeneron Pharmaceuticals, Inc.
- The report provides overview of Regeneron Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Regeneron Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Regeneron Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Regeneron Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Regeneron Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Regeneron Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Introduction

Report Coverage

Regeneron Pharmaceuticals, Inc. Snapshot

Regeneron Pharmaceuticals, Inc. Overview

Key Information

Key Facts

Regeneron Pharmaceuticals, Inc. - Research and Development Overview

Key Therapeutic Areas

Regeneron Pharmaceuticals, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Regeneron Pharmaceuticals, Inc. - Pipeline Products Glance

Regeneron Pharmaceuticals, Inc. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Regeneron Pharmaceuticals, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Regeneron Pharmaceuticals, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Regeneron Pharmaceuticals, Inc. - Drug Profiles

aflibercept

Product Description

Mechanism of Action

R&D Progress

alirocumab

Product Description

Mechanism of Action

R&D Progress

sarilumab

Product Description

Mechanism of Action

R&D Progress

dupilumab

Product Description

Mechanism of Action

R&D Progress

suptavumab

Product Description

Mechanism of Action

R&D Progress

fasinumab

Product Description

Mechanism of Action

R&D Progress

(aflibercept + nesvacumab)

Product Description

Mechanism of Action

R&D Progress

(aflibercept + rinucumab)

Product Description

Mechanism of Action

R&D Progress

evinacumab

Product Description

Mechanism of Action

R&D Progress

trevogrumab

Product Description

Mechanism of Action

R&D Progress

ziv-aflibercept (recombinant)

Product Description

Mechanism of Action

R&D Progress

REGN-19081909

Product Description

Mechanism of Action

R&D Progress

REGN-1979

Product Description

Mechanism of Action

R&D Progress

REGN-2810

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibodies for Ebola Virus Infection

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibodies for Middle East Respiratory Syndrome

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody to Agonize GITR for Oncology

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody to Inhibit LAG-3 for Oncology

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody to Inhibit PD-L1 for Oncology

Product Description

Mechanism of Action

R&D Progress

Oligonucleotides to Inhibit Transthyretin for Amyloidosis

Product Description

Mechanism of Action

R&D Progress

REGN-1001

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibodies for Blood Cancer and Solid Tumor

Product Description

Mechanism of Action

R&D Progress

Regeneron Pharmaceuticals, Inc. - Pipeline Analysis

Regeneron Pharmaceuticals, Inc. - Pipeline Products by Target

Regeneron Pharmaceuticals, Inc. - Pipeline Products by Route of Administration

Regeneron Pharmaceuticals, Inc. - Pipeline Products by Molecule Type

Regeneron Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action

Regeneron Pharmaceuticals, Inc. - Recent Pipeline Updates

Regeneron Pharmaceuticals, Inc. - Dormant Projects

Regeneron Pharmaceuticals, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

crotedumab

dapiclermin

enoticumab

nesvacumab

REGN-1400

REGN-846

rilonacept

ziv-aflibercept (recombinant)

Regeneron Pharmaceuticals, Inc. - Company Statement

Regeneron Pharmaceuticals, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Regeneron Pharmaceuticals, Inc. - Key Manufacturing Facilities

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Regeneron Pharmaceuticals, Inc., Key Information

Regeneron Pharmaceuticals, Inc., Key Facts

Regeneron Pharmaceuticals, Inc. - Pipeline by Indication, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Regeneron Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Regeneron Pharmaceuticals, Inc. - Combination Treatment Modalities in Pipeline, 2016

Regeneron Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016

Regeneron Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2016

Regeneron Pharmaceuticals, Inc. - Pre-Registration, 2016

Regeneron Pharmaceuticals, Inc. - Phase III, 2016

Regeneron Pharmaceuticals, Inc. - Phase II, 2016

Regeneron Pharmaceuticals, Inc. - Phase I, 2016

Regeneron Pharmaceuticals, Inc. - Preclinical, 2016

Regeneron Pharmaceuticals, Inc. - Discovery, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline by Target, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016

Regeneron Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016

Regeneron Pharmaceuticals, Inc. - Dormant Developmental Projects,2016

Regeneron Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016

Regeneron Pharmaceuticals, Inc., Other Locations

Regeneron Pharmaceuticals, Inc., Subsidiaries

Regeneron Pharmaceuticals, Inc., Key Manufacturing Facilities

List of Figures

Regeneron Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Regeneron Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Regeneron Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2016

Regeneron Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll